enVVeno Medical Corp
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | 100.0% | – | – | – | – | – | – | – | – | – | – | – | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| 134.3% | 69.5% | 104.7% | – | 595.4% | 74.9% | 106.9% | 39.8% | 80.1% | 3,103.9% | – | – | – | – | – | – | – | 307.2% | – | – | – | – | – | – | – | – | – | – | – | 16.3% | – | – | – | 15.0% | – | – | – | – | – | – | – | |
| -34.3% | 17.1% | -4.7% | 100.0% | -495.4% | 25.1% | -6.9% | 60.2% | 19.9% | 100.0% | 100.0% | – | – | – | – | – | – | -307.2% | – | – | – | – | – | – | – | – | – | – | – | -16.3% | – | – | – | -15.0% | – | – | – | – | – | – | – | |
| – | – | 40.3% | 476.6% | 154.5% | 199.3% | 774.2% | 336.4% | 1,019.1% | 962.6% | 1,001.9% | – | – | – | – | – | – | 7,288.8% | – | – | – | – | – | – | – | – | – | – | – | 361.8% | – | – | – | 432.6% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 6,021.1% | – | – | – | – | – | – | – | – | – | – | – | 400.1% | – | – | – | 392.4% | – | – | – | – | – | – | – | |
| 324.5% | 403.0% | 622.4% | 3,274.6% | 6,004.5% | 1,126.4% | 4,681.5% | 3,793.0% | 3,590.6% | 2,901.6% | 5,164.6% | – | – | – | – | – | – | 13,002.7% | – | – | – | – | – | – | – | – | – | – | – | 745.6% | – | – | – | 810.0% | – | – | – | – | – | – | – | |
| -358.8% | -532.5% | -627.1% | -3,174.6% | -6,499.9% | -1,101.3% | -4,688.4% | -3,732.8% | -3,570.8% | -5,905.5% | -5,064.6% | – | – | – | – | – | – | -13,309.9% | – | – | – | – | – | – | – | – | – | – | – | -761.9% | – | – | – | -825.0% | – | – | – | – | – | – | – | |
| 4.9% | 2.4% | 5.1% | 101.3% | 1,602.4% | 813.3% | 15,387.8% | 2,540.0% | 46.8% | 56.7% | 1.5% | – | – | – | – | – | – | 3.5% | – | – | – | – | – | – | – | – | – | – | – | 49.2% | – | – | – | 47.9% | – | – | – | – | – | – | – | |
| -364.3% | -505.2% | -645.4% | -3,218.8% | -8,087.8% | -1,783.9% | -15,282.4% | -6,052.3% | -3,524.0% | -5,848.7% | -5,037.1% | – | – | – | – | – | – | -13,999.9% | – | – | – | – | – | – | – | – | – | – | – | -685.6% | – | – | – | -767.1% | – | – | – | – | – | – | – | |
| 4.9% | 2.4% | 5.1% | 40.4% | 1,602.4% | 62.2% | 677.5% | 134.3% | – | -56.7% | 27.6% | – | – | – | – | – | – | -1.0% | – | – | – | – | – | – | – | – | – | – | – | 176.3% | – | – | – | -12.0% | – | – | – | – | – | – | – | |
| -364.3% | -505.2% | -645.4% | -3,218.8% | -8,087.8% | -1,783.9% | -15,282.4% | -6,052.3% | -3,524.0% | -5,848.7% | -5,037.1% | – | – | – | – | – | – | -13,999.9% | – | – | – | – | – | – | – | – | – | – | – | -685.6% | – | – | – | -767.1% | – | – | – | – | – | – | – | |
| -345.6% | -489.4% | -619.9% | -3,085.2% | -6,366.8% | -951.6% | 212.3% | -3,472.5% | -3,443.9% | -4,689.0% | -4,743.2% | – | – | – | – | – | – | -13,001.7% | – | – | – | – | – | – | – | – | – | – | – | -669.3% | – | – | – | -752.1% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.